Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs). - No Study Results Posted

Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs). (EUCLID)

This study has been completed.

Study NCT00058604 Information provided by Baylor College of Medicine

First Received: April 8, 2003 Last Updated: April 9, 2009 History of Changes

No Study Results Posted for this Study

About Study Results Reporting

Study Status:	This study has been completed.
Study Completion Date:	December 2008
Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)